Annual Current Assets
$3.44 B
+$829.29 M+31.82%
December 31, 2023
Summary
- As of February 20, 2025, JAZZ annual total current assets is $3.44 billion, with the most recent change of +$829.29 million (+31.82%) on December 31, 2023.
- During the last 3 years, JAZZ annual current assets has risen by +$595.86 million (+20.98%).
- JAZZ annual current assets is now at all-time high.
Performance
JAZZ Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$4.39 B
+$708.76 M+19.25%
September 30, 2024
Summary
- As of February 20, 2025, JAZZ quarterly total current assets is $4.39 billion, with the most recent change of +$708.76 million (+19.25%) on September 30, 2024.
- Over the past year, JAZZ quarterly current assets has increased by +$1.14 billion (+35.27%).
- JAZZ quarterly current assets is now at all-time high.
Performance
JAZZ Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
JAZZ Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.8% | +35.3% |
| 3 y3 years | +21.0% | +35.3% |
| 5 y5 years | +178.4% | +35.3% |
JAZZ Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | at high | +75.6% |
| 5 y | 5-year | at high | +110.7% | at high | +189.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Jazz Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.39 B(+19.3%) |
| Jun 2024 | - | $3.68 B(+4.0%) |
| Mar 2024 | - | $3.54 B(+3.0%) |
| Dec 2023 | $7.96 B(-3.3%) | $3.44 B(+5.8%) |
| Sep 2023 | - | $3.25 B(+7.8%) |
| Jun 2023 | - | $3.01 B(+8.1%) |
| Mar 2023 | - | $2.78 B(+6.8%) |
| Dec 2022 | $8.23 B(-15.1%) | $2.61 B(+1.3%) |
| Sep 2022 | - | $2.57 B(-0.7%) |
| Jun 2022 | - | $2.59 B(+3.6%) |
| Mar 2022 | - | $2.50 B(-4.2%) |
| Dec 2021 | $9.69 B(+162.1%) | $2.61 B(-0.6%) |
| Sep 2021 | - | $2.63 B(-11.0%) |
| Jun 2021 | - | $2.95 B(-6.7%) |
| Mar 2021 | - | $3.17 B(+11.5%) |
| Dec 2020 | $3.70 B(-5.4%) | $2.84 B(+11.1%) |
| Sep 2020 | - | $2.56 B(+11.0%) |
| Jun 2020 | - | $2.30 B(+51.7%) |
| Mar 2020 | - | $1.52 B(-6.9%) |
| Dec 2019 | $3.91 B(-1.5%) | $1.63 B(+7.2%) |
| Sep 2019 | - | $1.52 B(+11.0%) |
| Jun 2019 | - | $1.37 B(+4.9%) |
| Mar 2019 | - | $1.31 B(+5.8%) |
| Dec 2018 | $3.97 B(-4.5%) | $1.23 B(-15.7%) |
| Sep 2018 | - | $1.46 B(+12.0%) |
| Jun 2018 | - | $1.31 B(+16.0%) |
| Mar 2018 | - | $1.13 B(+16.3%) |
| Dec 2017 | $4.16 B(+2.5%) | $968.28 M(+16.5%) |
| Sep 2017 | - | $830.94 M(+25.4%) |
| Jun 2017 | - | $662.50 M(-12.0%) |
| Mar 2017 | - | $752.85 M(+0.6%) |
| Dec 2016 | $4.05 B(+95.3%) | $748.07 M(+0.5%) |
| Sep 2016 | - | $744.23 M(-39.5%) |
| Jun 2016 | - | $1.23 B(-3.1%) |
| Mar 2016 | - | $1.27 B(+1.0%) |
| Dec 2015 | $2.07 B | $1.26 B(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $1.31 B(+5.6%) |
| Jun 2015 | - | $1.24 B(+12.9%) |
| Mar 2015 | - | $1.10 B(+8.6%) |
| Dec 2014 | $2.32 B(+69.1%) | $1.02 B(+15.6%) |
| Sep 2014 | - | $878.52 M(+61.2%) |
| Jun 2014 | - | $544.91 M(+5.3%) |
| Mar 2014 | - | $517.32 M(-40.2%) |
| Dec 2013 | $1.37 B(-2.9%) | $864.62 M(+6.7%) |
| Sep 2013 | - | $810.07 M(+10.3%) |
| Jun 2013 | - | $734.18 M(+13.4%) |
| Mar 2013 | - | $647.37 M(+17.4%) |
| Dec 2012 | $1.41 B(+2499.0%) | $551.57 M(+43.3%) |
| Sep 2012 | - | $385.01 M(+28.1%) |
| Jun 2012 | - | $300.44 M(-8.2%) |
| Mar 2012 | - | $327.14 M(+64.3%) |
| Dec 2011 | $54.44 M(-11.1%) | $199.13 M(+30.9%) |
| Sep 2011 | - | $152.14 M(+11.8%) |
| Jun 2011 | - | $136.09 M(+43.5%) |
| Mar 2011 | - | $94.84 M(+27.4%) |
| Dec 2010 | $61.27 M(-13.0%) | $74.46 M(+132.1%) |
| Jun 2010 | - | $32.08 M(-17.2%) |
| Mar 2010 | - | $38.74 M(+4.8%) |
| Dec 2009 | $70.44 M(-4.2%) | $36.95 M(+26.8%) |
| Sep 2009 | - | $29.14 M(-10.9%) |
| Jun 2009 | - | $32.73 M(-2.4%) |
| Mar 2009 | - | $33.54 M(-23.8%) |
| Dec 2008 | $73.50 M(-19.6%) | $44.00 M(-36.9%) |
| Sep 2008 | - | $69.70 M(-0.7%) |
| Jun 2008 | - | $70.20 M(-41.1%) |
| Mar 2008 | - | $119.25 M(+2.7%) |
| Dec 2007 | $91.46 M(-25.6%) | $116.09 M(-19.9%) |
| Sep 2007 | - | $144.98 M(-10.0%) |
| Jun 2007 | - | $161.16 M(+103.3%) |
| Mar 2007 | - | $79.27 M(-13.4%) |
| Dec 2006 | $123.01 M(-7.8%) | $91.56 M(+191.8%) |
| Dec 2005 | $133.40 M | $31.38 M |
FAQ
- What is Jazz Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual current assets year-on-year change?
- What is Jazz Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly current assets year-on-year change?
What is Jazz Pharmaceuticals annual total current assets?
The current annual current assets of JAZZ is $3.44 B
What is the all time high annual current assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total current assets is $3.44 B
What is Jazz Pharmaceuticals annual current assets year-on-year change?
Over the past year, JAZZ annual total current assets has changed by +$829.29 M (+31.82%)
What is Jazz Pharmaceuticals quarterly total current assets?
The current quarterly current assets of JAZZ is $4.39 B
What is the all time high quarterly current assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total current assets is $4.39 B
What is Jazz Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, JAZZ quarterly total current assets has changed by +$1.14 B (+35.27%)